ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.000
+0.020 (2.04%)
At close: Oct 9, 2026, 4:00 PM EDT
1.007
+0.007 (0.72%)
After-hours: Oct 9, 2026, 7:30 PM EDT
ABVC BioPharma Employees
As of December 31, 2025, ABVC BioPharma had 19 total employees, including 16 full-time and 3 part-time employees. The number of employees did not change compared to the previous year. That makes ABVC BioPharma the 38,409th largest employer in the world and 5,546th in the United States.
Employees
19
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$374,033
Market Cap
25.92M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 19 | 0 | - | 16 | 3 |
| Dec 31, 2024 | 19 | 0 | - | 16 | 3 |
| Dec 31, 2023 | 19 | -4 | -17.39% | 16 | 3 |
| Dec 31, 2022 | 23 | -7 | -23.33% | 19 | 4 |
| Dec 31, 2021 | 30 | -4 | -11.76% | 28 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Seres Therapeutics | 66 |
| aTyr Pharma | 60 |
| Evaxion | 46 |
| BeyondSpring | 44 |
| Kyntra Bio | 34 |
| Quantum BioPharma | 17 |
| Atossa Therapeutics | 16 |
ABVC News
- 11 days ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 4 weeks ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 6 weeks ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 1 month ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 1 month ago - ABVC BioPharma Quarterly report: Q2 2026 - Filings
- 2 months ago - ABVC Biopharma Inc trading halted, news pending - TheFly
- 2 months ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 4 months ago - ABVC BioPharma Quarterly report: Q1 2026 - Filings